Transcriptional data: A new gateway to drug repositioning?

Drug Discovery Today

Volumn 18, Issue 7-8, 2013, Pages 350-357

  Iorio, Francesco ^a,d   Rittman, Timothy ^b   Ge, Hong ^c   Menden, Michael ^a   Saez Rodriguez, Julio ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASE STUDY; COMPUTER MODEL; DNA MICROARRAY; DRUG REPOSITIONING; ENTERITIS; GENE EXPRESSION; HUMAN; MUSCLE ATROPHY; NONHUMAN; PHENOTYPE; REVIEW;

ANIMALS; DATABASES, FACTUAL; DRUG REPOSITIONING; GENE EXPRESSION PROFILING; HUMANS; PHENOTYPE; TRANSCRIPTION, GENETIC;

EID: 84875718672     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2012.07.014     Document Type: Review

References (60)

1. B. Booth, and R. Zemmel Prospects for productivity Nat. Rev. Drug Discov. 3 2004 451 456 (Pubitemid 38618127)
2. F. Mangialasche Alzheimer's disease: clinical trials and drug development Lancet Neurol. 9 2010 702 716
3. S.M. Paul How to improve R&D productivity: the pharmaceutical industry's grand challenge Nat. Rev. Drug Discov. 9 2010 203 214
4. T.T. Ashburn, and K.B. Thor Drug repositioning: identifying and developing new uses for existing drugs Nat. Rev. Drug Discov. 3 2004 673 683 (Pubitemid 39173508)
5. C.R. Chong, and D.J. Sullivan New uses for old drugs Nature 448 2007 645 646 (Pubitemid 47236844)
6. L.A. Tartaglia Complementary new approaches enable repositioning of failed drug candidates Expert Opin. Investig. Drugs 15 2006 1295 1298 (Pubitemid 44615280)
7. R.C. Renaud, and H. Xuereb From the analyst's couch: erectile-dysfunction therapies Nat. Rev. Drug Discov. 1 2002 663 664
8. M.J. Keiser Predicting new molecular targets for known drugs Nature 462 2009 175 181
9. V.J. Haupt, and M. Schroeder Old friends in new guise: repositioning of known drugs with structural bioinformatics Brief. Bioinform. 12 2011 312 326
10. C. Andronis Literature mining, ontologies and information visualization for drug repurposing Brief. Bioinform. 12 2011 357 368
11. P. Sanseau Use of genome-wide association studies for drug repositioning Nat. Biotechnol. 30 2012 317 320
12. M. Iskar Drug discovery in the age of systems biology: the rise of computational approaches for data integration Curr. Opin. Biotechnol. 23 2012 609 616
13. Y.A. Lussier, and J.L. Chen The emergence of genome-based drug repositioning Sci. Transl. Med. 3 2011 96ps35
14. L. Chindelevitch Causal reasoning on biological networks: interpreting transcriptional changes Bioinformatics 28 2011 1114 1121
15. A. Kasarskis Integrative genomics strategies to elucidate the complexity of drug response Pharmacogenomics 12 2011 1695 1715
16. L. Pham Network-based prediction for sources of transcriptional dysregulation using latent pathway identification analysis Proc. Natl. Acad. Sci. U. S. A. 108 2011 13347 13352
17. D. di Bernardo Chemogenomic profiling on a genome-wide scale using reverse-engineered networks Nat. Biotechnol. 23 2005 377 383
18. J. Lamb The Connectivity Map: a new tool for biomedical research Nat. Rev. Cancer 7 2007 54 60 (Pubitemid 46020847)
19. M. Sirota Discovery and preclinical validation of drug indications using compendia of public gene expression data Sci. Transl. Med. 3 2011 96ra77
20. D.G. Mcart, and S-D. Zhang Identification of candidate small-molecule therapeutics to cancer by gene-signature perturbation in connectivity mapping PLoS ONE 6 2011 e16382
21. F. Iorio Identification of small molecules enhancing autophagic function from drug network analysis Autophagy 6 2010 1204 1205
22. F. Iorio Discovery of drug mode of action and drug repositioning from transcriptional responses Proc. Natl. Acad. Sci. U. S. A. 107 2010 14621 14626
23. A.J. Wolpaw Modulatory profiling identifies mechanisms of small molecule-induced cell death Proc. Natl. Acad. Sci. U. S. A. 108 2011 E771 E780
24. G. Hu, and P. Agarwal Human disease-drug network based on genomic expression profiles PLoS ONE 4 2009 e6536
25. D. Shigemizu Using functional signatures to identify repositioned drugs for breast, myelogenous leukemia and prostate cancer PLoS Comput. Biol. 8 2012 e1002347
26. M-H. Chen Gene expression-based chemical genomics identifies potential therapeutic drugs in hepatocellular carcinoma PLoS ONE 6 2011 e27186
27. J.T. Dudley Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease Sci. Trans. Med. 3 2011 96ra76
28. P. Khatri Profiling gene expression using Onto-Express Genomics 79 2002 266 270
29. A. Subramanian Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles Proc. Natl. Acad. Sci. U. S. A. 102 2005 15545 15550 (Pubitemid 41528093)
30. A. Califano Analysis of gene expression microarrays for phenotype classification Proc. Int. Conf. Intell. Syst. Mol. Biol. 8 2000 75 85
31. J.R. Nevins, and A. Potti Mining gene expression profiles: expression signatures as cancer phenotypes Nat. Rev. Genet. 8 2007 601 609 (Pubitemid 47077277)
32. D.R. Rhodes, and A.M. Chinnaiyan Integrative analysis of the cancer transcriptome Nat. Genet. 37 2005 S31 S37
33. T.R. Hughes Functional discovery via a compendium of expression profiles Cell 102 2000 109 126
34. S. Ramaswamy A molecular signature of metastasis in primary solid tumors Nat. Genet. 33 2002 49 54
35. J. Lamb The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease Science 313 2006 1929 1935 (Pubitemid 44497995)
36. H. Hieronymus Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators Cancer Cell 10 2006 321 330 (Pubitemid 44512193)
37. D.C. Hassane Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data Blood 111 2008 5654 5662
38. M. Lukk A global map of human gene expression Nat. Biotechnol. 28 2010 322 324
39. H. Parkinson ArrayExpress update-an archive of microarray and high-throughput sequencing-based functional genomics experiments Nucleic Acids Res. 39 2011 D1002 D1004
40. T. Barrett NCBI GEO: mining millions of expression profiles-database and tools Nucleic Acids Res. 33 2004 D562 D566
41. J.T. Dudley Disease signatures are robust across tissues and experiments Mol. Syst. Biol. 5 2009 1 8
42. C. Harrison Translational genetics: signatures for drug repositioning Nat. Rev. Genet. 12 2011 668 669
43. S. Claerhout Gene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancer PLoS ONE 6 2011 e24662
44. G. Jin A novel method of transcriptional response analysis to facilitate drug repositioning for cancer therapy Cancer Res. 72 2011 33 34
45. S.D. Kunkel mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass Cell Metab. 13 2011 627 638
46. G. Wei Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance Cancer Cell 10 2006 331 342 (Pubitemid 44512194)
47. D.C. Hassane Chemical genomic screening reveals synergism between parthenolide and inhibitors of the PI-3 kinase and mTOR pathways Blood 116 2010 5983 5990
48. P.M. Dean, and R.A. Lewis Molecular Diversity in Drug Design 1999 Kluwer Academic Publishers
49. D.W. Huang Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat. Protoc. 4 2008 44 57
50. A.C. Culhane GeneSigDB-a curated database of gene expression signatures Nucleic Acids Res. 38 2009 D716 D725
51. D.A. Hosack Identifying biological themes within lists of genes with EASE Genome Biol. 4 2003 R70
52. Y. Liu, and M. Ringnér Revealing signaling pathway deregulation by using gene expression signatures and regulatory motif analysis Genome Biol. 8 2007 R77
53. S. Zhang, and T. Gant A simple and robust method for connecting small-molecule drugs using gene-expression signatures BMC Bioinformatics 9 2008 258
54. S. Zhang, and T. Gant sscMap: an extensible Java application for connecting small-molecule drugs using gene-expression signatures BMC Bioinformatics 10 2009 236
55. J.M. Engreitz ProfileChaser: searching microarray repositories based on genome-wide patterns of differential expression Bioinformatics 27 2011 3317 3318
56. M. Vazquez MARQ: an online tool to mine GEO for experiments with similar or opposite gene expression signatures Nucleic Acids Res. 38 2010 W228 W232
57. E.S. Lander Array of hope Nat. Genet. 21 1999 3 4 (Pubitemid 29031483)
58. M. Iskar Drug-induced regulation of target expression PLoS Comput. Biol. 6 2010 1929 1935
59. S.B. Plaisier Rank-rank hypergeometric overlap: identification of statistically significant overlap between gene-expression signatures Nucleic Acids Res. 38 2010 e169
60. L. Licamele, and L. Getoor Indirect two-sided relative ranking: a robust similarity measure for gene expression data BMC Bioinformatics 11 2010 137